Mad1 suppresses bladder cancer cell proliferation by inhibiting human telomerase reverse transcriptase transcription and telomerase activity

Urology

Volumn 67, Issue 6, 2006, Pages 1335-1340

  Zou, Lin ^a   Zhang, Penghui ^a   Luo, Chunli ^a   Tu, Zhiguang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; HETERODIMER; LUCIFERASE; MAX PROTEIN; MITOSIS ARREST DEFICIENCY 1 PROTEIN; PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CANCER; CANCER CELL; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TUMOR GROWTH; TUMOR XENOGRAFT; XENOGRAFT;

ANIMALS; CELL CYCLE PROTEINS; CELL PROLIFERATION; DNA-BINDING PROTEINS; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NUCLEAR PROTEINS; TELOMERASE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 33744789685     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.12.029     Document Type: Article

References (24)

1. Jin D.Y., Spencer F., and Jeang K.T. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 93 (1998) 81-91
2. Cerni C., Skrzypek B., Popov N., et al. Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1. Oncogene 21 (2002) 447-459
3. Bejarano M.T., Albihn A., Cornvik T., et al. Inhibition of cell growth and apoptosis by inducible expression of the transcriptional repressor Mad1. Exp Cell Res 260 (2000) 61-72
4. Orlando C., Gelmini S., Selli C., et al. Telomerase in urological malignancy. J Urol 166 (2001) 666-673
5. Nakamura T.M., Morin G.B., Chapman K.B., et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 277 (1997) 955-965
6. Fujiwara M., Kamma H., Wu W., et al. Expression and alternative splicing pattern of human telomerase reverse transcriptase in human lung cancer cells. Int J Oncol 24 (2004) 925-930
7. Budiyanto A., Bito T., Kunisada M., et al. Inhibition of the epidermal growth factor receptor suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma cells. J Invest Dermatol 121 (2003) 1088-1094
8. Ohta Y., Hamada Y., Saitoh N., et al. Effect of the transcriptional repressor Mad1 on proliferation of human melanoma cells. Exp Dermatol 11 (2002) 439-447
9. Xu D., Popov N., Hou M., et al. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc Natl Acad Sci U S A 98 (2001) 3826-3831
10. Zou L., Zhang P.H., Luo C.L., et al. Transcript regulation of human telomerase reverse transcriptase by c-myc and mad1. Acta Biochim Biophys Sin 37 (2005) 32-38
11. Horikawa I., Cable P.L., Mazur S.J., et al. Downstream E-box-mediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription. evidence for an endogenous mechanism of transcriptional repression. Mol Biol Cell 13 (2002) 2585-2597
12. Wu K.J., Grandori C., Amacker M., et al. Direct activation of TERT transcription by c-myc. Nat Genet 21 (1999) 220-224
13. Braunstein I., Cohen-Barak O., Shachaf C., et al. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells. Cancer Res 61 (2001) 5529-5536
14. Paradis V., Bieche I., Dargere D., et al. hTERT expression in sporadic renal cell carcinomas. J Pathol 195 (2001) 209-217
15. Applied Biosystems. Relative quantification of gene expression. ABI Prism 7700 Sequence detection system user bulletin #2 (2001), Applied Biosystems, Foster City, California
16. Hu L.H., Chen F.H., Li Y.R., et al. Real-time determination of human telomerase reverse transcriptase mRNA in gastric cancer. World J Gastroenterol 10 (2004) 3514-3517
17. Komata T., Kondo Y., Kanzawa T., et al. Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells. Hum Gene Ther 13 (2002) 1015-1025
18. Roussel M.F., Ashmun R.A., Sherr C.J., et al. Inhibition of cell proliferation by the Mad1 transcriptional repressor. Mol Cell Biol 16 (1996) 2796-2801
19. Foley K.P., McArthur G.A., Queva C., et al. Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. EMBO J 17 (1998) 774-785
20. Dang C.V. c-myc target genes involved in cell growth, apoptosis and metabolism. Mol Cell Biol 19 (1999) 1-11
21. Gunes C., Lichtsteiner S., Vasserot A.P., et al. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. Cancer Res 60 (2000) 2116-2121
22. Lin S.Y., and Elledge S.J. Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113 (2003) 881-889
23. Gehring S., Rottmann S., Menkel A.R., et al. Inhibition of proliferation and apoptosis by the transcriptional repressor Mad1. Repression of Fas-induced caspase-8 activation. J Biol Chem 275 (2000) 10413-10420
24. Kraemer K., Fuessel S., Schmidt U., et al. Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. Clin Cancer Res 9 (2003) 3794-3800